Letrozole and CDK 4/6 Inhibitor for ER Positive, HER2 Negative Breast Cancer in Postmenopausal Women
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: ER Positive, HER2 Negative Breast Cancer
Interventions: DRUG: Letrozole, PD 0332991
Sponsor: Organisation for Oncology and Translational Research